Opus Genetics, Inc.

IRD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2009 FY2008 FY2007 FY2006 FY2005 FY2004 FY2003 FY2002
Assets
Cash & Equivalents $7.3M $369.1K
Accounts Receivable
Inventory
Total Current Assets
Property, Plant & Equipment
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets
Liabilities
Accounts Payable
Total Current Liabilities
Long-Term Debt
Total Liabilities
Stockholders' Equity
Retained Earnings
Total Stockholders' Equity $4.9M $-2.6M $958.2K $3.2M $4.8M $-564.2K $2.5M $2.7M
← Newer Page 3 of 4 Older →